Cornerstone Capital, Inc. Gilead Sciences, Inc. Transaction History

Cornerstone Capital, Inc.

$988 Million
Q2 2024

A detailed history of Cornerstone Capital, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cornerstone Capital, Inc. holds 35,534 shares of GILD stock, worth $2.8 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

35,534

Previous 39,594 10.25%

Holding current value

$2.8 Million

Previous $2.9 Million 15.97%

% of portfolio

0.25%

Previous 0.3%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$63.15 - $72.88 $256,389 - $295,892	-4,060 Reduced 10.25%	35,534 $2.44 Million
Q1 2024 May 01, 2024	SELL	$71.58 - $87.29 $413,732 - $504,536	-5,780 Reduced 12.74%	39,594 $2.9 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $21,072 - $22,990	-285 Reduced 0.62%	45,374 $3.4 Million
Q2 2023 Aug 21, 2023	BUY	$76.01 - $86.7 $38,005 - $43,350	500 Added 1.11%	45,659 $3.52 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $85,041 - $96,888	1,100 Added 2.5%	45,159 $3.75 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $81,327 - $116,758	1,305 Added 3.05%	44,059 $3.78 Million
Q3 2022 Oct 27, 2022	BUY	$59.54 - $68.01 $49,120 - $56,108	825 Added 1.97%	42,754 $2.64 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $184,704 - $208,032	-3,200 Reduced 7.09%	41,929 $2.59 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $253,747 - $317,972	-4,381 Reduced 8.85%	45,129 $2.68 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $149,224 - $169,372	-2,300 Reduced 4.44%	49,510 $3.6 Million
Q3 2021 Nov 09, 2021	BUY	$67.69 - $73.03 $337,434 - $364,054	4,985 Added 10.65%	51,810 $3.62 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $7,299 - $7,975	-115 Reduced 0.24%	46,825 $3.22 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $37,020 - $42,239	-617 Reduced 1.3%	46,940 $3.03 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $6,231 - $7,100	-110 Reduced 0.23%	47,557 $2.77 Million
Q3 2020 Oct 27, 2020	BUY	$62.1 - $78.08 $304,911 - $383,372	4,910 Added 11.48%	47,667 $3.01 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $141,135 - $163,884	1,951 Added 4.78%	42,757 $3.29 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $246,511 - $315,745	3,936 Added 10.68%	40,806 $3.05 Million
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $109,437 - $120,377	-1,776 Reduced 4.6%	36,870 $2.4 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $3,125 - $3,450	-50 Reduced 0.13%	38,646 $2.45 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $323,592 - $362,508	5,175 Added 15.44%	38,696 $2.52 Million
Q4 2018 Feb 11, 2019	SELL	$60.54 - $79.0 $2.03 Million - $2.65 Million	-33,525 Reduced 50.0%	33,521 $2.1 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $112,266 - $124,299	1,575 Added 2.41%	67,046 $5.18 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $61,960 - $72,274	955 Added 1.48%	65,471 $4.64 Million
Q1 2018 May 08, 2018	BUY	$72.84 - $88.8 $112,902 - $137,640	1,550 Added 2.46%	64,516 $4.86 Million
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $834,589 - $979,689	11,730 Added 22.89%	62,966 $4.51 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $3.69 Million - $4.38 Million	51,236	51,236 $4.15 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $98.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Capital, Inc. with notifications on news.

Account

Cornerstone Capital, Inc. Gilead Sciences, Inc. Transaction History